OTCM
CLPBY
Market cap13bUSD
Jun 18, Last price
5.75USD
1D
-0.35%
1Q
-12.75%
Jan 2017
-14.56%
Name
Coloplast A/S
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Coloplast A/S designs, produces, and commercializes a range of medical devices. The firm concentrates on creating and marketing healthcare products and services aimed at individuals experiencing sensitive and private medical conditions. Its activities are segmented into four main areas: Ostomy Care, which supplies products for patients with a surgically rerouted intestinal tract; Continence Care, providing solutions for those with urinary system dysfunctions or damage; Urology Care, addressing issues affecting the kidneys, urinary tract, or the male reproductive system; and Wound & Skin Care, focused on the management of chronic wounds and the provision of both preventive and therapeutic skin care items. Coloplast distributes its merchandise to various entities, including hospitals, medical facilities, wholesalers, and pharmacies.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||